DK0433167T3 - Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem - Google Patents

Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem

Info

Publication number
DK0433167T3
DK0433167T3 DK90403537.5T DK90403537T DK0433167T3 DK 0433167 T3 DK0433167 T3 DK 0433167T3 DK 90403537 T DK90403537 T DK 90403537T DK 0433167 T3 DK0433167 T3 DK 0433167T3
Authority
DK
Denmark
Prior art keywords
image
piperidine derivatives
processes
preparation
pathology
Prior art date
Application number
DK90403537.5T
Other languages
English (en)
Inventor
Gilbert Regnier
De La Faverie J F Renaud
Alain Lombet
Jean-Pierre Iliou
Jean-Paul Vilaine
Jean-Pierre Bidouard
Albert Lenaers
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0433167T3 publication Critical patent/DK0433167T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90403537.5T 1989-12-12 1990-12-12 Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem DK0433167T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8916384A FR2655649B1 (fr) 1989-12-12 1989-12-12 Nouveaux derives de la piperidine, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
DK0433167T3 true DK0433167T3 (da) 1994-05-02

Family

ID=9388394

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90403537.5T DK0433167T3 (da) 1989-12-12 1990-12-12 Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem

Country Status (15)

Country Link
US (1) US5126356A (da)
EP (1) EP0433167B1 (da)
JP (1) JPH07100695B2 (da)
AT (1) ATE102186T1 (da)
AU (1) AU629076B2 (da)
CA (1) CA2031839A1 (da)
DE (1) DE69007045T2 (da)
DK (1) DK0433167T3 (da)
ES (1) ES2052217T3 (da)
FR (1) FR2655649B1 (da)
IE (1) IE66909B1 (da)
NZ (1) NZ236231A (da)
OA (1) OA09473A (da)
PT (1) PT96156B (da)
ZA (1) ZA909768B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
JPWO2003099788A1 (ja) * 2002-05-28 2005-09-22 日本ケミファ株式会社 ピペリジン誘導体
WO2005030721A1 (ja) * 2003-09-30 2005-04-07 Nippon Chemiphar Co., Ltd. ピペリジン誘導体
EP3316877B1 (en) 2015-07-02 2019-10-30 Horizon Orphan LLC Ado-resistant cysteamine analogs and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB780027A (en) * 1955-01-20 1957-07-31 Schering Corp 3-piperidyl ethers and thioethers
FR2514353A2 (fr) * 1980-04-28 1983-04-15 Synthelabo Derives de piperidine et leur application en therapeutique
EP0077427B1 (fr) * 1981-10-15 1985-05-22 Synthelabo Dérivés de pipéridine, leur procédé de préparation et leur application en thérapeutique
US4529730A (en) * 1981-10-21 1985-07-16 Synthelabo Piperidine derivatives, their preparation and pharmaceutical compositions containing them
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring

Also Published As

Publication number Publication date
DE69007045D1 (de) 1994-04-07
FR2655649B1 (fr) 1994-07-08
PT96156A (pt) 1991-09-30
EP0433167A1 (fr) 1991-06-19
DE69007045T2 (de) 1994-08-04
ES2052217T3 (es) 1994-07-01
CA2031839A1 (fr) 1991-06-13
OA09473A (fr) 1992-11-15
JPH06340626A (ja) 1994-12-13
PT96156B (pt) 1998-05-29
NZ236231A (en) 1992-07-28
ZA909768B (en) 1991-09-25
FR2655649A1 (fr) 1991-06-14
IE904434A1 (en) 1991-06-19
US5126356A (en) 1992-06-30
JPH07100695B2 (ja) 1995-11-01
AU629076B2 (en) 1992-09-24
AU6793690A (en) 1991-06-20
EP0433167B1 (fr) 1994-03-02
IE66909B1 (en) 1996-02-07
ATE102186T1 (de) 1994-03-15

Similar Documents

Publication Publication Date Title
ATE40368T1 (de) Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR950700265A (ko) 고지혈증 치료에 유용한 벤조티아제핀 화합물(hypolipidaemic ben zothiazepine compounds)
NO810684L (no) Fremgangsmaate ved fremstilling av indanderivater.
ATE17728T1 (de) Xanthinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE111912T1 (de) Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
ATE6645T1 (de) Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DK0433167T3 (da) Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ATE116647T1 (de) Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FR2612517B1 (fr) Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant
SE8300855L (sv) Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem
FI853233L (fi) 1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE28871T1 (de) Disubstituierte piperidine,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2070959T3 (es) Utilizacion de derivados del bis(4-hidroxifeniltio)metano en el tratamiento de la diabetes mellitus.
ATE7224T1 (de) Propanolamin-derivate, ihre salze, verfahren zu ihrer herstellung und pharmazeutische praeparate.
ATE103909T1 (de) Sulfonamide mit tetrazolylrest, verfahren zu ihrer herstellung sowie arzneimittel.
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
PT93904A (pt) Processo para a preparacao de novos derivados benzotiazolinonicos e de composicoes farmaceuticas que os contem
SE8203477L (sv) 4-aminobensylaminderivat, ett forfarande for deras framstellning och deras anvendning som farmaceutiska
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE27278T1 (de) Thieno(2,3-6)pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE3295T1 (de) Clavulansaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.